Diagnosing and Treating Immune Thrombocytopenic Purpura
The group continues their analysis of emergencies by exploring their first hematologic emergency: Immune thrombocytopenic purpura (ITP). They explain how to confirm that the diagnosis is in fact ITP, and subsequently, provide a treatment plan.
Effects of PD-1 Inhibitors on Real-world Treatment Patterns, Outcomes in Advanced HCC
Platinum Chemotherapy, PARP Inhibitors for Gastric or Esophageal Cancers
Identifying HR and NER Deficiencies in Gastric Cancer for Targeted Treatment Strategies